Concepedia

Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries

Sarah Yardly Jenkins, Danielle Resar, Zachary Panos, Alan Staple, Melynda Watkins, David H. Brown Ripin, Carolyn Amole

Journal of the International AIDS Society · 2023 · 12 citations · 13 references

DOIFull text

Open access

Abstract

Accelerating access to affordable, generic CAB-LA can transform progress towards HIV epidemic control. This vision of impact at scale in prevention is achievable, if informed by results-backed approaches to introduction.

References

13

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 773 citations · Full text

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock et al. · The Lancet · 2022 · 498 citations · Full text

, , +9

Use of modern contraception increases when more methods become available: analysis of evidence from 1982–2009

John A. Ross, John Stover · Global Health Science and Practice · 2013 · 226 citations · Full text

Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa

Diantha Pillay, Kayla Stankevitz, Michele Lanham et al. · PLoS ONE · 2020 · 149 citations · Full text

Medicines Regulation in Africa: Current State and Opportunities

Margareth Ndomondo-Sigonda, Shan Naidoo, Alexander Dodoo et al. · Pharmaceutical Medicine · 2017 · 145 citations · Full text